Policy and Advocacy Department of IAVI held a training on Scientific literacy research ethics and translation of research findings into policies and best practices Trainer of Trainers (ToT) on the 15-18 November at the Raddison Red Hotel in Johannesburg. The aim of the training is to ensure that Attendees have a better understanding of: Scientific...
What is the role of resource tracking in sustainable financing of health R&D for greater impact in Africa? Join the Africa Health R&D Week, a continental forum on domestic resource mobilization for health research and development (R&D) in Africa. Register here
Under the umbrella of SAHTAC and Campaigning for Cancer a first regional Health Technology Assessment International (HTAi)-endorsed workshop was held on October 26, 2022, in Johannesburg. It was co-hosted by the HTAi’s Public and Citizen Involvement working group. The workshop focused on patient and public involvement (PPI) in HTA or healthcare decision making in Southern...
On 26th October 2022, the South African Health Technologies Coalition (SAHTAC), through its Regulatory Harmonisation work, supported the South African Health Products Regulatory Authority (SAHPRA) to host a webinar titled: SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3. More than 337 people dialed into the webinar which was characterized by many questions and...
The National Health Research Strategy Priority Framework Workshop was held online as a Webinar on the 19th of October 2022. The main objective of the workshop was to conduct a retrospective explanatory analysis to examine the policy determination that is how the policy got to be on the agenda, how it was initiated and formulated,...
SAHTAC participated in the first joint World Health Summit co-hosted with WHO on 16 to 18 October in Berlin, Germany. The Summit brought together the most prominent names in global health from all sectors in all regions of the world. Held under the patronage of German Federal Chancellor Olaf Scholz, French President Emmanuel Macron, Senegal’s...
The Covid-19 pandemic not only exposed the weaknesses in our healthcare system but also revealed the deep-seated issues that remain prevalent with pharmaceutical companies responsible for developing lifesaving technology. The deep-seated issues pertaining to access to medical resources in third-world countries, where many countries are often left behind in the process of accessing lifesaving technology....
Across the globe, research helps find the root cause of the health challenges or diseases in our society, identify ways to improve behaviours of the affected community, and find solutions to our health issues. Clinical research has critical in bringing new vaccines to our health system. Clinical research – aimed at evaluating a medical, surgical, or...
It is time to treat the scourge of Tuberculosis scourge with the same urgency as we did the COVID-19 pandemic. As we emerge from the devastating toll of the pandemic on people’s lives and on global economies, we must wake up to face the staggering toll of 1.5 million Tuberculosis deaths and 10 million new infections...
Across Africa, local manufacturing and pharmaceutical companies are responding to the urgent need for locally produced medical products and technologies despite the existing regulatory challenges. We can support manufacturing capacity by expediting the establishment and operationalisation of the African Medicines Agency (AMA). In November 2021, after 15 countries signed and ratified the AMA treaty, the AMA...
